ArriVent BioPharma (AVBP) logo

AVBP earnings date, and what happened the last 4 times

Next report

Mon Nov 16

Quality Score today -7

After the close, in 20 days. Expected: the company has not confirmed it.

AVBP closed higher after 1 of its last 4 reports. On average it closed -2.2% the session after a report.

The moment AVBP reports

  • Its figures, in plain words
  • How it moves after, beside its last four
  • Its Quality Score going in, and after
Get an alert when AVBP reports, with its figures

See it live, free until tomorrow morning. No account. No card. Then keep going with a free account.

What happened after AVBP's last 4 reports

AVBP's last 4 earnings reports
ReportedScore
going in
GapReaction
Aug 12, 20262026 · After close5estimated-2.3%-4.6%
May 11, 20262026 · After close5estimated-2.2%-0.2%
Mar 5, 20262026 · After close4estimated+0.6%-7.2%
Nov 10, 20252025 · Before open-4estimated+3.5%+3.1%
  • Aug 12, 2026, after the close: the next session AVBP opened -2.3% and closed -4.6%, and five sessions on it stood -4.6%. Its Quality Score going in was 5 (Below Average), estimated.
  • May 11, 2026, after the close: the next session AVBP opened -2.2% and closed -0.2%, and five sessions on it stood -6.8%. Its Quality Score going in was 5 (Below Average), estimated.
  • Mar 5, 2026, after the close: the next session AVBP opened +0.6% and closed -7.2%, and five sessions on it stood -4.6%. Its Quality Score going in was 4 (Below Average), estimated.
  • Nov 10, 2025, before the open: that session AVBP opened +3.5% and closed +3.1%, and five sessions on it stood +14.7%. Its Quality Score going in was -4 (Poor), estimated.

Across these 4 reports AVBP opened higher after 2 of 4 and closed higher after 1 of 4; on average it opened -0.1%, closed -2.2%, and stood -0.3% five sessions on. Its Quality Score is -7 today, against 5 going into its Aug 12, 2026 report.

Gap: where the stock opened the session after the report. Reaction: where that session closed. Both against the close before the report. The largest of the 4: -7.2% after the Mar 5, 2026 report. A score marked estimated was worked out afterwards from that day's prices and filings; Breakaway has recorded every score live since Sep 9 2026.

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

Pro members see AVBP's reaction live as a report comes out, the release's figures, and an optional alert before it reports.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

Questions about AVBP's earnings

As of Oct 27, 2026: ArriVent BioPharma (AVBP): expected to report Mon Nov 16, after the close. AVBP closed higher after 1 of its last 4 reports. Its Quality Score is -7 (Poor). Scores as of 12:12 AM ET, 15 minutes behind.

When is AVBP's next earnings date?

Expected to report Mon Nov 16, after the close, a date Breakaway expects from the company's usual timing; the company has not confirmed it. AVBP closed higher after 1 of its last 4 reports. Past behavior, not a forecast.

Does AVBP report before or after the market?

AVBP is expected to report Mon Nov 16, after the close. Its last 4 reports came 3 after the close and 1 before the open.

How did AVBP stock react to its last earnings report?

Aug 12, 2026, after the close: the next session AVBP opened -2.3% and closed -4.6%, and five sessions on it stood -4.6%.

Does AVBP stock usually go up after earnings?

AVBP closed higher after 1 of its last 4 reports. On average it closed -2.2% the session after a report, after opening -0.1%. Past behavior, not a forecast.

ArriVent BioPharma's page has its Quality Score, its chart, and its insiders' trades. Who reports this week: the earnings calendar.

Past behavior, not a forecast. The score is delayed at least 15 minutes; the reports' moves are as they closed.

Our top-scored stocks' record: Oct 2021 to Sep 2026, before costs; recorded live since Sep 9 2026.

Breakaway publishes impersonal securities research and analytical tools: one formula, the same score for everyone. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security.

Market data from a licensed vendor. The age of every quote is shown on the page.

This browser is too old to show this page right. Update it, or open this page in Safari or Chrome.